228 related articles for article (PubMed ID: 15069616)
1. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer.
Huang MF; Zhu YQ; Chen ZF; Xiao J; Huang X; Xiong YY; Yang GF
World J Gastroenterol; 2005 May; 11(19):2975-80. PubMed ID: 15902740
[TBL] [Abstract][Full Text] [Related]
3. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
4. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype.
Shibata N; Watari J; Fujiya M; Tanno S; Saitoh Y; Kohgo Y
Hum Pathol; 2003 Jan; 34(1):32-40. PubMed ID: 12605364
[TBL] [Abstract][Full Text] [Related]
5. Localization of syndecan-1 in human gastric mucosa associated with ulceration.
Tanabe H; Yokota K; Kohgo Y
J Pathol; 1999 Feb; 187(3):338-44. PubMed ID: 10398089
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies.
Mitselou A; Ioachim E; Peschos D; Charalabopoulos K; Michael M; Agnantis NJ; Vougiouklakis T
Exp Oncol; 2007 Mar; 29(1):54-60. PubMed ID: 17431390
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin expression as a differentiation marker in gastric cancer.
Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Karatzas G
Hepatogastroenterology; 1998; 45(24):2437-42. PubMed ID: 9951940
[TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype.
Motoshita J; Nakayama H; Taniyama K; Matsusaki K; Yasui W
Pathol Int; 2006 Apr; 56(4):200-5. PubMed ID: 16634965
[TBL] [Abstract][Full Text] [Related]
9. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of gastric and intestinal mucin phenotypes of gastric carcinoma.
Mabuchi N; Niwa Y; Hirooka Y; Ohmiya N; Itoh A; Maeda O; Ando T; Goto H
Hepatogastroenterology; 2008; 55(88):2277-81. PubMed ID: 19260522
[TBL] [Abstract][Full Text] [Related]
13. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of peroxisome proliferator-activated receptor in histologically different human gastric cancer tissues.
Nomura S; Nakajima A; Ishimine S; Matsuhashi N; Kadowaki T; Kaminishi M
J Exp Clin Cancer Res; 2006 Sep; 25(3):443-8. PubMed ID: 17167986
[TBL] [Abstract][Full Text] [Related]
15. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
16. Paranuaclear E-cadherin in gastric adenocarcinoma.
Carpenter PM; Al-Kuran RA; Theuer CP
Am J Clin Pathol; 2002 Dec; 118(6):887-94. PubMed ID: 12472282
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.
Contreras HR; Fabre M; Granés F; Casaroli-Marano R; Rocamora N; Herreros AG; Reina M; Vilaró S
Biochem Biophys Res Commun; 2001 Aug; 286(4):742-51. PubMed ID: 11520060
[TBL] [Abstract][Full Text] [Related]
18. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells.
Murata-Kamiya N; Kurashima Y; Teishikata Y; Yamahashi Y; Saito Y; Higashi H; Aburatani H; Akiyama T; Peek RM; Azuma T; Hatakeyama M
Oncogene; 2007 Jul; 26(32):4617-26. PubMed ID: 17237808
[TBL] [Abstract][Full Text] [Related]
20. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]